Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investments in Childhood Community Resources and Subsequent Adult Health Outcomes.

JAMA network open·2026
Same author

Driving physical activity policy for improved population health demands political action.

British journal of sports medicine·2025
Same author

An ecological framework for population health and well-being.

Progress in cardiovascular diseases·2025
Same author

Socioeconomic milieu and culture: Forcing factors and the Most fundamental determinant of health.

Progress in cardiovascular diseases·2025
Same author

Association between governmental spending on social services and health care use among low-income older adults.

Health affairs scholar·2025
Same author

Pursuing healthy homeownership: an evaluation of the neighborhood health trajectories of shared equity homeowners.

BMC public health·2025
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Related Experiment Videos

Web-based collaborative care for type 1 diabetes: a pilot randomized trial.

Kelly P McCarrier1, James D Ralston, Irl B Hirsch

  • 1Department of Health Services, University of Washington , Seattle, Washington 98195, USA. kpm25@u.washington.edu

Diabetes Technology & Therapeutics
|April 7, 2009
PubMed
Summary
This summary is machine-generated.

A Web-based diabetes case management program improved self-efficacy in adults with type 1 diabetes but did not significantly improve glycemic control. Further research is needed to confirm its impact on health outcomes.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Digital Health
  • Diabetes Management

Background:

  • Type 1 diabetes requires ongoing management to prevent complications.
  • Electronic medical record (EMR)-based Web programs offer new avenues for diabetes care.
  • Assessing the impact of digital health interventions on patient outcomes is crucial.

Purpose of the Study:

  • To evaluate a Web-based case management program integrated with EMR for type 1 diabetes.
  • To determine its effect on glycemic control (HbA1c) and self-efficacy.

Main Methods:

  • A 12-month pilot randomized controlled trial was conducted.
  • Adults (21-49 years) with type 1 diabetes and HbA1c >7.0% were randomized.
  • Intervention group received usual care plus the Web program; control received usual care.

Main Results:

  • The intervention group showed a significant increase in diabetes self-efficacy (P=0.04).
  • A decrease in HbA1c was observed in the intervention group but was not statistically significant (P=0.160).
  • 77 patients were enrolled, with a mean baseline HbA1c of 8.0%.

Conclusions:

  • The Web-based program positively impacted self-efficacy in type 1 diabetes patients.
  • The intervention's effect on glycemic control requires further investigation in larger trials.
  • Digital health tools show promise for improving aspects of diabetes self-management.